Acurx Pharmaceuticals to add up to $1 million in bitcoin for treasury reserve, following MicroStrategy's playbook
The adoption of bitcoin by Acurx could enhance investor confidence, similar to MicroStrategy's experience.
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
The adoption of bitcoin by Acurx could enhance investor confidence, similar to MicroStrategy's experience.
What happened, with direct paths to the underlying reporting
Acurx Pharmaceuticals approved purchasing $1 million in bitcoin as treasury asset. ACXP shares dipped over 6% after an 8% premarket surge. CEO highlights bitcoin's limited supply as a strong store of value. Companies like MicroStrategy see significant stock gains from bitcoin investments. Bitcoin's price increased by 122% this year, signaling growing investor interest.
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.